S
Super Religare Laboratories
Pathology laboratory network in india
About Super Religare Laboratories
Established in 1995 as Specialty Ranbaxy Limited, a joint venture between Ranbaxy Laboratories and US-based Specialty Laboratories, the company now known as SRL Diagnostics has undergone significant evolution. It was founded by brothers Malvinder Mohan Singh and Shivinder Mohan Singh, who inherited their family's stake in Ranbaxy Laboratories. The company's journey involved several name changes, including SRL Ranbaxy Limited and later Super Religare Laboratories, before becoming SRL Diagnostics after its acquisition by Fortis Healthcare in 2011. In a major strategic move, the company rebranded to Agilus Diagnostics in May 2023, a name derived from the Latin word for 'agility', to reflect its responsiveness to changing customer needs.
SRL Diagnostics operates as a subsidiary of Fortis Healthcare and has established itself as one of India's largest diagnostic chains. The company's business is structured around a hub-and-spoke model, utilizing a vast network of laboratories and collection centers to provide diagnostic services across India. Its revenue is generated through a transaction-led model, earning from each test conducted. The business caters to a diverse clientele, including individual walk-in patients (B2C), corporate clients for employee health check-ups, hospital and clinical partnerships, and government public-private partnership (PPP) programs. To expand its reach, SRL also offers a franchise model for collection centers and pathology labs, allowing entrepreneurs to partner with the established brand.
The company provides a comprehensive range of over 3,500 tests in pathology and radiology, from routine blood work to advanced diagnostics. This includes specialized areas like allergy screening, cardiac markers, diabetes monitoring, genetic testing, and cancer diagnostics. SRL has introduced health packages tailored for different demographics, such as children, seniors, and preventive wellness screenings for various lifestyle diseases. A key service offering is home sample collection, which provides convenience to customers in over 150 cities. The company has also embraced digital solutions, developing its own laboratory information management system (CLIMS), and offering online reports, a mobile app, and virtual doctor consultations. To stay at the forefront of diagnostics, SRL invests in research and development, focusing on new test development and leveraging technologies like AI for improved accuracy.
Source: Dealroom company dataAt a glance
- Founded
- 1995
- Headquarters
- Gurugram, India
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Avigo Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Super Religare Laboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Super Religare Laboratories on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.